Departamento académico
(FM) Oftalmología
Publications (21) Publications in which a researcher has participated
2022
-
A Cross-Sectional Observational Study of the Relationship between Outdoor Exposure and Myopia in University Students, Measured by Conjunctival Ultraviolet Autofluorescence (CUVAF)
Journal of Clinical Medicine, Vol. 11, Núm. 15
-
A Screening Tool for Self-Evaluation of Risk for Age-Related Macular Degeneration: Validation in a Spanish Population
Translational Vision Science and Technology, Vol. 11, Núm. 6
-
ACE-Vitamin Index and Risk of Glaucoma: The SUN Project
Nutrients, Vol. 14, Núm. 23
-
Carbohydrate intake and risk of glaucoma in the sun cohort
European Journal of Ophthalmology, Vol. 32, Núm. 2, pp. 999-1008
-
Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy
Indian Journal of Ophthalmology, Vol. 70, Núm. 5, pp. 1626-1633
-
Clinical Characterization of Inpatients with Acute Conjunctivitis: A Retrospective Analysis by Natural Language Processing and Machine Learning
Applied Sciences (Switzerland), Vol. 12, Núm. 23
-
Clinical characteristics of full thickness macular holes that closed without surgery
British Journal of Ophthalmology, Vol. 106, Núm. 10, pp. 1463-1468
-
Comparative Study of Refraction between Wave Front-Based Refraction and Autorefraction without and with Cycloplegia in Children and Adolescents
Children, Vol. 9, Núm. 1
-
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes
Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324
-
Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative Study
Patient Preference and Adherence, Vol. 16, pp. 587-604
-
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
The Lancet, Vol. 399, Núm. 10326, pp. 729-740
-
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
The Lancet, Vol. 399, Núm. 10326, pp. 741-755
-
Encuesta sobre las preferencias quirúrgicas entre los glaucomatólogos en España
Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 6, pp. 310-316
-
External Validation and Clinical Applicability of Two Optical Coherence Tomography–Based Risk Calculators for Detecting Glaucoma
Translational Vision Science and Technology, Vol. 11, Núm. 7
-
Healthy Lifestyle Score and Incidence of Glaucoma: The Sun Project
Nutrients, Vol. 14, Núm. 4
-
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry
Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053
-
Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation
Biomedicines, Vol. 10, Núm. 7
-
Recovery course of foveal microstructure in the nonsurgical resolution of full-thickness macular hole
Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 260, Núm. 10, pp. 3173-3183
-
Respuesta al comentario «El menosprecio de lo próximo», relativo al editorial «Inteligencia artificial y Oftalmología: Estado actual»
Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 7, pp. 418-419
-
Technological advances in ocular trabecular meshwork in vitro models for glaucoma research
Biotechnology and Bioengineering, Vol. 119, Núm. 10, pp. 2698-2714